Modification of phenytoin crystals .3. Influence of 3-butanoyloxymethyl-5,5-diphenylhydantoin on solution-phase crystallization and related crystal properties

被引:18
作者
Chow, AHL [1 ]
Gordon, JD [1 ]
Szeitz, A [1 ]
Young, JWM [1 ]
机构
[1] UNIV BRITISH COLUMBIA,FAC PHARMACEUT SCI,VANCOUVER,BC V5Z 1M9,CANADA
基金
英国医学研究理事会;
关键词
phenytoin; 3-butanoyloxymethyl-5,5-diphenylhydantoin; particle morphology; crystal defects; crystal disorder; dissolution rate;
D O I
10.1016/0378-5173(95)04059-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The modification of the physical properties of phenytoin (5,5-diphenylhydantoin; DPH) by recrystallization from methanol has been investigated as a function of the concentration of 3-butanoyloxymethyl-5,5-diphenylhydantoin (BMDPH; a potential ester prodrug of DPH) added to the crystallization medium. With increasing concentration of BMDPH in the crystallization solutions (0.5-12 g l(-1)), there exhibited a curvilinear increase in the sorption of BMDPH (0.01-0.5 mol%) and the specific surface area of the DPH crystals; a drastic reduction in crystallization yield and a progressive change of crystal habit from needles to elongated plates. Powder X-ray diffraction studies on the samples indicated essentially the same diffraction patterns and lattice spacings for both the pure and the BMDPH-doped DPH crystals, suggesting that the doped crystals did not undergo gross structural modification. However, the enthalpy of fusion, Delta H-f, and the entropy of fusion, Delta S-f, as determined by differential scanning calorimetry, reduced by as much as 17% for the samples doped at 7 g l(-1) BMDPH (equivalent to a sorption of 0.39 mol%), reflecting a significant upsurge in both the enthalpy and entropy of the DPH crystals. The disruption index of BMDPH, as quantitatively defined by the slope of the linear regression of Delta S-f on the ideal molar entropy of mixing, Delta dS(ideal)(m) 73 +/- 11 suggesting that the additive is capable of inducing substantial lattice disorder and disruption (about 73 times that due to simple random mixing alone) in the DPH crystals. Vigorous repeated washing of the samples with 5% methanol in water removed similar to 25 +/- 1.3% w/w of sorbed BMDPH and a negligibly small amount of DPH (1.2 +/- 0.1% w/w), suggesting the BMDPH resides mostly (similar to 75%) within the crystals. The initial dissolution rate (IR) at 25 and 37 degrees C of the various samples increased sigmoidally, reaching a maximal increment of 4-5-fold for the samples prepared at BMDPH concentrations above 5 gl(-1) whereas the intrinsic dissolution rate, IDR (i.e. IR divided by the initial surface area), at both temperatures attained a plateauing maximum (similar to 2-fold increase) for the crystals grown at and above 1 gl(-1) BMDPH. The observed improvement of IDR is likely due to an increase in the concentration of crystal defects (both within and on the surface of the crystals) and/or to a change of crystal habit.
引用
收藏
页码:11 / 19
页数:9
相关论文
共 8 条
[1]   TRANSPORT CONTROL IN HETEROGENEOUS REACTIONS [J].
BIRCUMSHAW, LL ;
RIDDIFORD, AC .
QUARTERLY REVIEWS, 1952, 6 (02) :157-185
[2]   MODIFICATION OF PHENYTOIN CRYSTALS - INFLUENCE OF 3-ACETOXYMETHYL-5,5-DIPHENYLHYDANTOIN ON SOLUTION-PHASE CRYSTALLIZATION AND RELATED CRYSTAL PROPERTIES [J].
CHOW, AHL ;
HSIA, CK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 75 (2-3) :219-230
[3]   PHYSICAL FACTORS INFLUENCING THE AQUEOUS DISSOLUTION RATE OF ACETAMINOPHEN CRYSTALS DOPED WITH PARA-ACETOXYACETANILIDE - EVALUATION BY MULTIPLE LINEAR-REGRESSION [J].
CHOW, AHL ;
GRANT, DJW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 51 (02) :129-135
[4]  
CHOW AHL, 1985, INT J PHARM, V24, P238
[5]   MODIFICATION OF PHENYTOIN CRYSTALS .2. INFLUENCE OF 3-PROPANOYLOXYMETHYL-5,5-DIPHENYLHYDANTOIN ON SOLUTION-PHASE CRYSTALLIZATION AND RELATED CRYSTAL PROPERTIES [J].
GORDON, JD ;
CHOW, AHL .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 79 (2-3) :171-181
[6]   A THEORETICAL TREATMENT OF CHANGES IN ENERGY AND ENTROPY OF SOLIDS CAUSED BY ADDITIVES OR IMPURITIES IN SOLID-SOLUTION [J].
PIKAL, MJ ;
GRANT, DJW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 39 (03) :243-253
[7]   PHENYTOIN PRODRUGS .3. WATER-SOLUBLE PRODRUGS FOR ORAL AND OR PARENTERAL USE [J].
VARIA, SA ;
SCHULLER, S ;
SLOAN, KB ;
STELLA, VJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (08) :1068-1073
[8]   A DISRUPTION INDEX FOR QUANTIFYING THE SOLID-STATE DISORDER INDUCED BY ADDITIVES OR IMPURITIES .1. DEFINITION AND EVALUATION FROM HEAT OF FUSION [J].
YORK, P ;
GRANT, DJW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 25 (01) :57-72